Company profile
Shield Therapeutics company profile
Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.
Business identity
- Contact email
- [email protected]
- Phone number
- +44 (0) 191 511 8500
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2008-01-01, Year
Headquarters
- Headquarters
- Weybridge, England, United Kingdom
- Postal code
- KT13 0TT
- Country code
- GB
- Continent
- Europe